LT Pharma
ActiveSummary
The computed 12-month bankruptcy probability of LT Pharma is 3.4% (moderate). For LT Pharma, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €1.1m and a net result of €122,899. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 84% of 6,532 sector peers (NACE 47, financial year 2023). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 25 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 92050B0015/00A002 | Wallonia | 2,400 m² | 1 · 147 m² | 5.4 m · 2 |